Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Vaxinano; Institute for Translational Research in Inflammation - U 1286 (INFINITE (Ex-Liric)); Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille); Laboratoire de Virologie - ULR 3610 (Laboratoire de Virologie); Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille); Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 (RID-AGE); Institut Pasteur de Lille; Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille); Lille Inflammation Research International Center - U 995 (LIRIC); Centre Universitaire de Mesures et d'Analyses Université de Lille (CUMA); Université de Lille, Droit et Santé; Centre d'Etudes et de recherche en Santé-Travail-Environnement (CERESTE); CSIC-Barcelone; Faculteit der Aard- en Levenswetenschappen, Vrije Universiteit; Vrije Universiteit Amsterdam Amsterdam (VU); INSTITUTE OF ENVIRONMENTAL AND BIOLOGICAL SCIENCES LANCASTER GBR; Partenaires IRSTEA; Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)-Institut national de recherche en sciences et technologies pour l'environnement et l'agriculture (IRSTEA)
    • بيانات النشر:
      HAL CCSD
      MDPI
    • الموضوع:
      2024
    • Collection:
      LillOA (HAL Lille Open Archive, Université de Lille)
    • نبذة مختصرة :
      International audience ; Nanoparticles are increasingly being studied as antigen delivery systems for immunization with nasal vaccines. The addition of adjuvants is still generally required in many nanoparticle formulations, which can induce potential side effects owing to mucosal reactogenicity. In contrast, maltodextrin nanoparticles do not require additional immunomodulators, and have been shown to be efficient vaccine delivery systems. In this review, the development of maltodextrin nanoparticles is presented, specifically their physico-chemical properties, their ability to load antigens and deliver them into airway mucosal cells, and the extent to which they trigger protective immune responses against bacterial, viral, and parasitic infections. We demonstrate that the addition of lipids to maltodextrin nanoparticles increases their potency as a vaccine delivery system for nasal administration.
    • Relation:
      hal-04453094; https://hal.science/hal-04453094; https://hal.science/hal-04453094/document; https://hal.science/hal-04453094/file/Fasquelle%20et%20al%202024%20-%20Maltodextrin-nanoparticles%20as%20a%20delivery%20system%20for%20nasal%20vaccines%20-%20a%20review.pdf
    • الرقم المعرف:
      10.3390/pharmaceutics16020247
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.8350611